Aberrant intracellular metabolism of T‐ <scp>DM</scp> 1 confers T‐ <scp>DM</scp> 1 resistance in human epidermal growth factor receptor 2‐positive gastric cancer cells
Hongbin Wang(Chinese Academy of Sciences), Liguang Lou(Shanghai Institute of Materia Medica)
Cited by 67
Related Papers
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity <i>in vitro</i> and <i>in vivo</i>
|Cancer Science|2011|519
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
|Cancer Science|2018|368
Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist
|Journal of Cellular and Molecular Medicine|2018|59
Antiviral effects of ferric ammonium citrate
|Cell Discovery|2018|57